1. Name and Address of Reporting Person*
C/O GROSVENOR CAPITAL MANAGEMENT |
900 N. MICHIGAN AVENUE, SUITE 1100 |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/04/2008
|
3. Issuer Name and Ticker or Trading Symbol
SGX PHARMACEUTICALS, INC.
[ SGXP ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
|
|
|
Indirect Beneficial Owner |
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
1. Name and Address of Reporting Person*
C/O GROSVENOR CAPITAL MANAGEMENT |
900 N. MICHIGAN AVENUE, SUITE 1100 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
|
|
|
Indirect Beneficial Owner |
|
1. Name and Address of Reporting Person*
C/O GROSVENOR CAPITAL MANAGEMENT |
900 N. MICHIGAN AVENUE, SUITE 1100 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
|
|
|
Indirect Beneficial Owner |
|
1. Name and Address of Reporting Person*
C/O GROSVENOR CAPITAL MANAGEMENT |
900 N. MICHIGAN AVENUE, SUITE 1100 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
|
|
|
Indirect Beneficial Owners |
|
1. Name and Address of Reporting Person*
C/O GROSVENOR CAPITAL MANAGEMENT LP |
900 N. MICHIGAN AVENUE, SUITE 1100 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
|
|
|
Direct Beneficial Owner |
|
1. Name and Address of Reporting Person*
C/O GROSVENOR CAPITAL MANAGEMENT |
900 N. MICHIGAN AVENUE, SUITE 1100 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
|
|
|
Direct Beneficial Owner |
|
|
BVF PARTNERS L.P., By BVF Inc., its General Partner, By /s/ Mark N. Lampert, President |
04/14/2008 |
|
BIOTECHNOLOGY VALUE FUND, L.P., By: BVF Partners L.P., its General Partner, By: BVF Inc., its General Partner, By: /s/ Mark N. Lampert, President |
04/14/2008 |
|
BIOTECHNOLOGY VALUE FUND II, L.P., By: BVF Partners L.P., its General Partner, By: BVF Inc., its General Partner, By /s/ Mark N. Lampert, President |
04/14/2008 |
|
BVF INVESTMENTS, L.L.C., By: BVF Partners L.P., its Manager, By: BVF Inc., its General Partner, By: /s/ Mark N. Lampert, President |
04/14/2008 |
|
BVF INC., By: /s/ Mark N. Lampert, President |
04/14/2008 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |